Figure 6 | Scientific Reports

Figure 6

From: Active ingredients Isorhamnetin of Croci Srigma inhibit stomach adenocarcinomas progression by MAPK/mTOR signaling pathway

Figure 6The alternative text for this image may have been generated using AI.

IH inhibits the colony formation, migration of HGC-27 and AGS cells. (A) Colony formation of IH-treated HGC-27 cells detected by clone formation assay. (B) Colony forming ratio in IH-treated HGC-27 cells. (C) Colony formation of IH-treated AGS cells detected by clone formation assay. (D) Colony forming ratio in IH-treated AGS cells. (E) Migration of IH-treated HGC-27 cells. (F) Percent of wound closure (%) of HGC-27 cells. (G) Cell cycle of IH-treated HGC-27 cells (left); Cell cycle phase of IH-treated HGC-27 cells (right). (H) Cell cycle of IH-treated AGS cells (left); Cell cycle phase of IH-treated AGS cells (right). Values are mean ± SD, n = 3, *P < 0.05, **P < 0.01 vs. control.

Back to article page